DAPAGLIFLOZIN-METFORMIN ER 10-500 MG TABLET
For 30 tablets
Pharmacies pay
$24.06 filed
30 × $0.80198 per EA
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D paid
$314.36 filed
30 × $10.47878 per EA, Part D average
Medicare's price is not your price.
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
The spread
13.1× estimated
Medicare paid 13.1× what pharmacies pay.
Part D averages every strength and form sold under “Dapagliflozin-Metformin ER” / “Dapaglifloz Propaned/Metformin” into one figure, so it is not specific to this NDC.
OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)
Cost-plus estimate
$32.67 estimated
$24.06 + $3.61 (15%) + $5.00 fee per fill = $32.67
This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
DAPAGLIFLOZIN-METFORMIN ER 10-500 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as dapagliflozin and metformin hydrochloride.
FDA gives its dosage form as “tablet, extended release” and “tablet, film coated, extended release” and its route as oral.
FDA lists 6 labelers (the companies named on the label) for its NDCs, among them Macleods Pharmaceuticals Limited, Aurobindo Pharma Limited and Sun Pharmaceutical Industries, Inc.
FDA lists it under 2 Established Pharmacologic Classes: Biguanide and Sodium-Glucose Cotransporter 2 Inhibitor.
The NADAC file of 2026-10-14 prices it under 6 NDCs (National Drug Codes).
NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $24.06 for 30 tablets (30 × $0.80198 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.
What NADAC measures · Why 30 tablets · NADAC explanation codes
All 6 NDCs
- 33342-0407-07 · Macleods Pharmaceuticals Limited · $0.80198 per EA · eff. 2026-09-23 filed
- 59651-0156-30 · Aurobindo Pharma Limited · $0.80198 per EA · eff. 2026-09-23 filed
- 63304-0027-30 · Sun Pharmaceutical Industries, Inc. · $0.80198 per EA · eff. 2026-09-23 filed
- 67877-0621-30 · Ascend Laboratories, LLC · $0.80198 per EA · eff. 2026-09-23 filed
- 70748-0103-06 · Lupin Pharmaceuticals, Inc. · $0.80198 per EA · eff. 2026-09-23 filed
- 72205-0436-01 · Novadoz Pharmaceuticals LLC · $0.80198 per EA · eff. 2026-09-23 filed
Other strengths, forms and brands
8 other products in the NADAC file share the FDA nonproprietary name dapagliflozin and metformin hydrochloride with DAPAGLIFLOZIN-METFORMIN ER 10-500 MG TABLET.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| DAPAGLIFLOZIN-METFORMIN ER 5-1,000 MG TABLET | $0.46063 per EA filed | $10.47878 per EA filed |
| DAPAGLIFLOZIN-METFORMIN ER 5-500 MG TABLET | $0.70725 per EA filed | $10.47878 per EA filed |
| DAPAGLIFLOZIN-METFORMIN ER 10-1,000 MG TABLET | $0.71952 per EA filed | $10.47878 per EA filed |
| DAPAGLIFLOZIN-METFORMIN ER 10-500 MG TABLET this page | $0.80198 per EA filed | $10.47878 per EA filed |
| XIGDUO XR 2.5 MG-1,000 MG TAB | $9.60825 per EA filed | $13.6073 per EA filed |
| XIGDUO XR 5 MG-1,000 MG TABLET | $9.59236 per EA filed | $13.6073 per EA filed |
| XIGDUO XR 5 MG-500 MG TABLET | $19.18159 per EA filed | $13.6073 per EA filed |
| XIGDUO XR 10 MG-1,000 MG TAB | $19.20443 per EA filed | $13.6073 per EA filed |
| XIGDUO XR 10 MG-500 MG TABLET | $19.2391 per EA filed | $13.6073 per EA filed |
Part D is one average per brand and generic name, over every strength and form.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
Compared with its class
The middle of its 6 NDCs’ NADAC prices is $0.80198 per EA filed.
Of the 71 other products in FDA’s Biguanide class priced per EA, 52 have a higher middle NADAC price and 19 a lower one. The one in the middle is SYNJARDY XR 5-1,000 MG TABLET, at $5.61111 per EA filed (eff. 2026-09-23).
Of the 39 other products in FDA’s Sodium-Glucose Cotransporter 2 Inhibitor class priced per EA, 34 have a higher middle NADAC price and 5 a lower one. The one in the middle is XIGDUO XR 2.5 MG-1,000 MG TAB, at $9.60825 per EA filed (eff. 2026-09-23).
Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
What Medicare paid
Medicare Part D paid $314.36 for 30 tablets, at an average of $10.47878 per EA in 2024 (2024-01-01 to 2024-12-31) for “Dapagliflozin-Metformin ER” and “Dapaglifloz Propaned/Metformin”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).
That average covers 12,164 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.
Medicare's price is not your price.
What Part D spending measures · Which Medicare figure OpenBill compares · How the spread is worked out
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 30 tablets? Is it lower than what I would pay through my insurance?
- If you have Medicare Part D: what is my plan’s copay or coinsurance for it? The Part D average on this page is not what you pay.
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Questions
- Why is the comparison with Medicare for DAPAGLIFLOZIN-METFORMIN ER 10-500 MG TABLET labelled estimated?
- Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Dapagliflozin-Metformin ER / Dapaglifloz Propaned/Metformin: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on brand name.
Related pages
Its pharmacologic classes
Related in the same class
- SYNJARDY XR 10-1,000 MG TABLET
- SYNJARDY 12.5-1,000 MG TABLET
- TRIJARDY XR 10-5-1,000 MG TAB
- INVOKAMET XR 150-1,000 MG TAB
- JARDIANCE 10 MG TABLET